EN DE
STOCK COMPARISON

Jiangsu Skyray Instrument vs Keysight Technologies: Fair Value & Quality

Both stocks run through our valuation models. Here is how Jiangsu Skyray Instrument (300165) and Keysight Technologies (KEYS) compare, as of Aug 11, 2026.

As of Aug 11, 2026, Fair Value Calculator sees Keysight Technologies as the less overvalued of the two: Jiangsu Skyray Instrument trades at ¥5.39 versus a fair value of ¥0.91 (-83%), while Keysight Technologies trades at $341 versus $84.16 (-75%).
Jiangsu Skyray Instrument
300165.SHE · CNY · Health Care
-83%
upside to fair value
overvalued
Price¥5.39
Fair Value¥0.91
Quality54/100
Keysight Technologies
KEYS · USD · Information Technology
-75%
upside to fair value
overvalued
Price$341
Fair Value$84.16
Quality71/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Jiangsu Skyray InstrumentKeysight Technologies
Valuation
P/E (TTM)50.8×
0.68×P/S (TTM)8.87×
0.41×P/B9.19×
EV/EBITDA38.2×
PEG1.13×
Profitability
-36%Net margin17%
6%Operating margin19%
-19%Return on equity18%
-3%Return on assets6%
Growth
5%Revenue growth (YoY)32%
-23.9%Avg. growth/yr (3Y)-0.3%
-7.9%Avg. growth/yr (5Y)5.0%
Balance & size
1.01×Debt / equity0.43×
$423MMarket cap$54B
weakGrowth qualityhealthy

Keysight Technologies leads: 2 to 8 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Jiangsu Skyray Instrumentof which business quality 53 · market factors 54 Keysight Technologiesof which business quality 71 · market factors 73
ProfitabilityMargins and returns on capital today
4
52
Quality GrowthAre margins and returns improving?
41
47
CashflowEarnings quality: real cash, not paper profit
100
89
Fin. StrengthBalance sheet, leverage, solvency risk
27
76
InvestmentDisciplined investing over empire-building
100
59
Low VolatilityCalm price path (market factor)
45
42
MomentumPrice trend over the last 3–12 months (market factor)
58
82
52W MomentumDistance to the 52-week high (market factor)
56
92
Net IssuanceBuybacks instead of dilution
70
96

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Jiangsu Skyray Instrument

DCF Models¥1.08
Dividend Discount¥1.54
Asset-Based¥1.41
Growth DCF¥3.76

8 of 8 models see the stock below the current price.

Keysight Technologies

DCF Models$95.80
Earnings-Based$36.69
Dividend Discount$5.75
Multiples$81.40
Asset-Based$23.04
Growth DCF$104
Economic Profit$46.70
Growth Earnings$86.39

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Jiangsu Skyray Instrument
Bear ¥0.82Fair Value ¥0.91Bull ¥1.18
¥5.39 = current price (white tick)
Keysight Technologies
Bear $63.12Fair Value $84.16Bull $105
$341 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Jiangsu Skyray Instrument · Health Care

Quality score54 · above median
Fair value upside-83% · bottom 25%

Keysight Technologies · Information Technology

Quality score71 · Top 25%
Fair value upside-75% · bottom 25%

Bottom line

As of Aug 11, 2026, Fair Value Calculator sees Keysight Technologies as the less overvalued of the two: Jiangsu Skyray Instrument trades at ¥5.39 versus a fair value of ¥0.91 (-83%), while Keysight Technologies trades at $341 versus $84.16 (-75%).

Keysight Technologies has the higher quality score (71/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.